BACKGROUND: Many studies have employed voxel-based morphometry (VBM) of MRI images as an automated method of investigating cortical gray matter differences in schizophrenia. However, results from these studies vary widely, likely due to different methodological or statistical approaches. OBJECTIVE: To use VBM to investigate gray matter differences in schizophrenia in a sample significantly larger than any published to date, and to increase statistical power sufficiently to reveal differences missed in smaller analyses. METHODS: Magnetic resonance whole brain images were acquired from four geographic sites, all using the same model 1.5T scanner and software version, and combined to form a sample of 200 patients with both first episode and chronic schizophrenia and 200 healthy controls, matched for age, gender and scanner location. Gray matter concentration was assessed and compared using optimized VBM. RESULTS: Compared to healthy controls, schizophrenia patients showed significantly less gray matter concentration in multiple cortical and subcortical regions, some previously unreported. Overall, we found lower concentrations of gray matter in regions identified in prior studies, most of which reported only subsets of the affected areas. CONCLUSIONS: Gray matter differences in schizophrenia are most comprehensively elucidated using a large, diverse and representative sample.
BACKGROUND: Many studies have employed voxel-based morphometry (VBM) of MRI images as an automated method of investigating cortical gray matter differences in schizophrenia. However, results from these studies vary widely, likely due to different methodological or statistical approaches. OBJECTIVE: To use VBM to investigate gray matter differences in schizophrenia in a sample significantly larger than any published to date, and to increase statistical power sufficiently to reveal differences missed in smaller analyses. METHODS: Magnetic resonance whole brain images were acquired from four geographic sites, all using the same model 1.5T scanner and software version, and combined to form a sample of 200 patients with both first episode and chronic schizophrenia and 200 healthy controls, matched for age, gender and scanner location. Gray matter concentration was assessed and compared using optimized VBM. RESULTS: Compared to healthy controls, schizophreniapatients showed significantly less gray matter concentration in multiple cortical and subcortical regions, some previously unreported. Overall, we found lower concentrations of gray matter in regions identified in prior studies, most of which reported only subsets of the affected areas. CONCLUSIONS: Gray matter differences in schizophrenia are most comprehensively elucidated using a large, diverse and representative sample.
Authors: T E Schlaepfer; G J Harris; A Y Tien; L W Peng; S Lee; E B Federman; G A Chase; P E Barta; G D Pearlson Journal: Am J Psychiatry Date: 1994-06 Impact factor: 18.112
Authors: Matcheri S Keshavan; Richard D Sanders; John A Sweeney; Vaibhav A Diwadkar; Gerald Goldstein; Jay W Pettegrew; Nina R Schooler Journal: Am J Psychiatry Date: 2003-07 Impact factor: 18.112
Authors: Hema Ananth; Ioana Popescu; Hugo D Critchley; Catriona D Good; Richard S J Frackowiak; Raymond J Dolan Journal: Am J Psychiatry Date: 2002-09 Impact factor: 18.112
Authors: T William J Moorhead; Dominic E Job; Heather C Whalley; Tracy L Sanderson; Eve C Johnstone; Stephen M Lawrie Journal: Neuroimage Date: 2004-05 Impact factor: 6.556
Authors: Andrew M McIntosh; Dominic E Job; T William J Moorhead; Lesley K Harrison; Karen Forrester; Stephen M Lawrie; Eve C Johnstone Journal: Biol Psychiatry Date: 2004-10-15 Impact factor: 13.382
Authors: M Kubicki; M E Shenton; D F Salisbury; Y Hirayasu; K Kasai; R Kikinis; F A Jolesz; R W McCarley Journal: Neuroimage Date: 2002-12 Impact factor: 6.556
Authors: Robert W Buchanan; Alan Francis; Celso Arango; Karl Miller; David M Lefkowitz; Robert P McMahon; Patrick E Barta; Godfrey D Pearlson Journal: Am J Psychiatry Date: 2004-02 Impact factor: 18.112
Authors: Vicente Molina; Gemma Galindo; Benjamín Cortés; Alba G Seco de Herrera; Ana Ledo; Javier Sanz; Carlos Montes; Juan A Hernández-Tamames Journal: Eur Arch Psychiatry Clin Neurosci Date: 2010-12-28 Impact factor: 5.270
Authors: Päivikki Tanskanen; Khanum Ridler; Graham K Murray; Marianne Haapea; Juha M Veijola; Erika Jääskeläinen; Jouko Miettunen; Peter B Jones; Edward T Bullmore; Matti K Isohanni Journal: Schizophr Bull Date: 2008-11-17 Impact factor: 9.306
Authors: Jun Hua; Nicholas I S Blair; Adrian Paez; Ann Choe; Anita D Barber; Allison Brandt; Issel Anne L Lim; Feng Xu; Vidyulata Kamath; James J Pekar; Peter C M van Zijl; Christopher A Ross; Russell L Margolis Journal: Schizophr Res Date: 2018-11-06 Impact factor: 4.939
Authors: Nathaniel E Anderson; Keith A Harenski; Carla L Harenski; Michael R Koenigs; Jean Decety; Vince D Calhoun; Kent A Kiehl Journal: Hum Brain Mapp Date: 2018-11-15 Impact factor: 5.038
Authors: Judith M Segall; Jessica A Turner; Theo G M van Erp; Tonya White; H Jeremy Bockholt; Randy L Gollub; Beng C Ho; Vince Magnotta; Rex E Jung; Robert W McCarley; S Charles Schulz; John Lauriello; Vince P Clark; James T Voyvodic; Michele T Diaz; Vince D Calhoun Journal: Schizophr Bull Date: 2008-11-07 Impact factor: 9.306